Patients’ Group | ROI 1 (10−3 mm2/s) | ROI 2 (10−3 mm2/s) | ROI 3 (10−3 mm2/s) | ADClesion Mean (10−3 mm2/s) | ADCmin Mean (10−3 mm2/s) | ADC NL Mean | ADClesion/ ADC NL Ratio (%) |
---|---|---|---|---|---|---|---|
EGFR Mutation | 0.79 ± 0.24 | 0.82 ± 0.26 | 0.82 ± 0.26 | *0.81 ± 0.25 | 0.76 ± 0.24 | 0.87 | 94 |
Non-EGFR mutation | 0.8 ± 0.21 | 0.83 ± 0.23 | 0.83 ± 0.26 | 0.82 ± 0.23 | 0.76 ± 0.21 | 0.92 | 94 |
p = 0.956 | p = 0.985 | ||||||
The mean of ADC value of non-lesion sites | *0.89 ± 0.21 | ||||||
*p = 0.636 |